The spectra, classification, and rationale of ultraviolet-protective intraocular lenses.

American Journal of Ophthalmology (Impact Factor: 4.02). 01/1987; 102(6):727-32. DOI: 10.1016/0002-9394(86)90400-9
Source: PubMed

ABSTRACT I measured the spectral transmittance of 16 implantable intraocular lenses from 12 manufacturers and examined the rationale for using ultraviolet-absorptive intraocular lenses to protect pseudophakic individuals from photic retinopathy. Each ultraviolet-protective lens was classified by the wavelength at which its spectral transmittance fell to 10% in the blue or ultraviolet region of the spectrum. Current ultraviolet-protective intraocular lenses differ in the effectiveness of their protection against photic retinopathy, and product descriptions may be misleading.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Ultraviolet-blocking intraocular lenses (IOLs) are used routinely in cataract surgery and are widely accepted. Blue-blocking IOLs, however, have been much debated since their inception. In this article, we will review the advantages and disadvantages of blue-blocking IOLs. In experimental and animal studies, acute blue light exposure induces retinal damage and the use of blue-blocking IOLs lessens this damage. Many large epidemiologic studies have further investigated this relationship between blue light exposure and the development of age-related macular degeneration, and have shown conflicting results. Visual performance and circadian rhythm disturbances have also been explored in patients with blue-blocking IOLs; no significant negative effects have been shown. The current literature on blue-blocking IOLs is contradictory. Studies have failed to conclusively prove that blue-blocking lenses provide photoprotection against age-related macular degeneration or cause any significant detrimental effects on visual function or circadian rhythms.
    Current opinion in ophthalmology 11/2013; DOI:10.1097/ICU.0000000000000016 · 2.64 Impact Factor
  • Source
  • Source